A Federal Court judge has made his feelings known about a ruling by the NSW Supreme Court last year that found judges have no power to shut unregistered group members out of a class action, but said he was “just a single judge” and was bound by the decision.
Change has never fazed Slater and Gordon practice group leader Mathew Chuk, who has used the ever-evolving class action world and tumultuous times at his law firm to build an impressive career.
Plaintiffs law firm Slater & Gordon is considering a shareholder class action against the a2 Milk company over its 2021 financial year guidance, which was downgraded after weak baby formula sales to China.
Lawyerly is pleased to announce the winners of its inaugural Litigation Rising Stars competition, which honours 30 lawyers under the age of 40 for their work in high-stakes litigation.
The stage is set for a beauty parade of two shareholder class actions against Freedom Foods and Deloitte, and the judge overseeing the cases has embraced the recommendation of the High Court to appoint an independent barrister to represent group members in the contest.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff’s defect and negligence claims had a better chance of succeeding.
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF — including pre-implantation genetic testing — are the targets of a new class action investigation.
A judge has urged parties in a class action against Westpac over superannuation fees to hold an in-person mediation, saying that success rates have “plummeted” during the COVID-19 pandemic as more settlement talks are held virtually.
The trustee of Mayfair Group’s collapsed IPO Wealth Fund has denied claims in a class action that it misled investors who lost $86 million when the fund was wound up, and says it is fully indemnified for the class action’s claims under an agreement with the fund.
Slater & Gordon has argued discovery is becoming “unduly onerous” in a cross-claim filed by Arnold Bloch Leibler in a class action accusing the law firm of breaching its duty of care by greenlighting Slate & Gordon’s $1.2 billion acquisition of Quindell.